About this trial

This study aims to improve how doctors diagnose infections in patients with broken bones around joint replacements. Currently, there are no clear guidelines to help determine when an infection is present, making treatment decisions difficult. By studying how often infections are found through lab tests and identifying factors that predict infection, the investigators hope to create better ways to diagnose and care for these patients.

Eligibility criteria

Qualifiers

Adult patients (>18 years old) with periprosthetic fractures around primary or revision hip or knee arthroplasty

Patients requiring operative management for these fractures (fixation or revision arthroplasty)

Patients presenting to the University of Chicago Medical Center during two (2) year period (October 2025 to October 2027)

Disqualifiers

Patients undergoing non-operative management for periprosthetic fractures

Any documented or reported history of past prosthetic joint infection of the involved joint

Sinus tract at the time of presentation at the involved joint

Trial design

Treatments tested in this trial

  • Not applicable- observational study

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
The University of Chicago Medical Center60637, ChicagoIllinois, United States

Sponsors and collaborators

University of Chicago

Lead sponsor